Form 4: Inspire Medical Director Acquires Shares as Compensation

Sentiment:

Insider Trading Report


Inspire Medical Systems, Inc. Director Casey M. Tansey acquired 133 shares of common stock at $128 per share as part of the company's non-employee director compensation policy.

Summary

  • Casey M. Tansey, a Director of Inspire Medical Systems, Inc. (INSP), acquired 133 shares of common stock.
  • The transaction occurred on July 15, 2025, with shares valued at $128 each.
  • These shares were received in lieu of cash fees, consistent with the company's Non-Employee Director Compensation Policy.
  • Following this transaction, Casey M. Tansey directly holds 22,014 shares.
  • Additionally, 500 shares are held indirectly by The Kimberly Tansey Irrevocable Trust, and another 500 shares are held indirectly by The Kylie Tansey Irrevocable Trust.

Sentiment

Score: 7

Explanation: The acquisition of shares by a director, especially as part of a compensation policy, is generally viewed positively as it aligns the director's interests with those of shareholders. The transaction being under a 10b5-1 plan suggests it's a routine, pre-planned event rather than a speculative trade, which adds to the positive sentiment regarding corporate governance and transparency.

Positives

  • Director Casey M. Tansey acquired 133 shares of common stock, increasing direct ownership.
  • The acquisition was part of the company's Non-Employee Director Compensation Policy, indicating alignment of director interests with shareholders by receiving equity instead of cash.
  • The transaction was made pursuant to a Rule 10b5-1 plan, suggesting a pre-planned and transparent acquisition.

Risks

  • The document does not detail specific risks beyond the general SEC warning about intentional misstatements or omissions of facts constituting Federal Criminal Violations.

Future Outlook

The document does not provide any forward-looking statements or guidance.

Industry Context

This Form 4 filing is a routine disclosure of an insider transaction and does not provide broader industry context or trends.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Compensation Policy ImplementationShares of common stock were received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy, indicating a governance practice that aligns director incentives with shareholder value.07/15/2025Positive impact on corporate governance by promoting equity ownership among directors, fostering long-term alignment with company performance and shareholder interests.
Rule 10b5-1 Plan DisclosureThe transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), indicating a pre-planned and transparent trading arrangement.07/15/2025Enhances transparency and reduces the perception of opportunistic insider trading, contributing positively to corporate governance and investor confidence.

Related Party Transactions

  • Indirect beneficial ownership of 500 shares by The Kimberly Tansey Irrevocable Trust.
  • Indirect beneficial ownership of 500 shares by The Kylie Tansey Irrevocable Trust.

Stakeholder Impact

  • Shareholders: The acquisition of shares by a director, especially as part of compensation, generally signals confidence in the company's future and aligns director interests with shareholder value.

Key Dates

DateDescription
07/15/2025Date of earliest transaction for the acquisition of 133 shares of common stock by Casey M. Tansey.
07/16/2025Date the Form 4 was signed and filed.

Recommendation

hold

Keywords

Inspire Medical Systems, INSP, SEC Form 4, Insider Trading, Director Compensation, Share Acquisition, Equity Compensation, Casey M. Tansey, Stock Purchase, Corporate Governance

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.